Spanish Foundation for Neurometrics Development — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications1liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Active Cathodal tDCSEpilepsy is the fourth overall neurologic disorder, regardless of age and gender, affecting more than 50 million people worldwide. Modern epidemiological studies indicate that the global annualized cumulative incidence ranges between 42.8 and 67.8 new cases per 100,000 people each year, with figures scaling up to 139 per 100,000 in low- and middle-income regions. A community-based study conducted in France concluded that up to 22.5% of patients could be classified as presenting drug-resistant epilepsy. This group presents significant hazards such as an increased risk of death, injuries, psychosocial dysfunction, and a reduced quality of life.	Épilepsie	Non applicable	À vérifier	United Kingdom	À vérifier
Active Cathodal tDCSEpilepsy is the fourth overall neurologic disorder, regardless of age and gender, affecting more than 50 million people worldwide. Modern epidemiological studies indicate that the global annualized cumulative incidence ranges between 42.8 and 67.8 new cases per 100,000 people each year, with figures scaling up to 139 per 100,000 in low- and middle-income regions. A community-based study conducted in France concluded that up to 22.5% of patients could be classified as presenting drug-resistant epilepsy. This group presents significant hazards such as an increased risk of death, injuries, psychosocial dysfunction, and a reduced quality of life.	Épilepsie	Non applicable	À vérifier	United Kingdom	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Active Cathodal tDCS	Épilepsie	Non applicable	NCT05825274	TDCs to Treat Drug-resistant Epilepsy	COMPLETED

Publications

1

Molécule	Indication / population	Titre	Journal	Date
Active Cathodal tDCS		Efficacy of tDCS-primed iTBS in major depressive disorder: A randomized, sham-controlled trial with exploratory resting motor threshold analyses.	Journal of affective disorders